107 related articles for article (PubMed ID: 10325704)
1. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children.
Agertoft L; Andersen A; Weibull E; Pedersen S
Arch Dis Child; 1999 Mar; 80(3):241-7. PubMed ID: 10325704
[TBL] [Abstract][Full Text] [Related]
2. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
Dahlström K; Thorsson L; Larsson P; Nikander K
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671
[TBL] [Abstract][Full Text] [Related]
3. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
Cates CJ; Adams N; Bestall J
Cochrane Database Syst Rev; 2001; (2):CD001491. PubMed ID: 11405994
[TBL] [Abstract][Full Text] [Related]
4. How much nebulised budesonide reaches infants and toddlers?
Lødrup Carlsen KC; Nikander K; Carlsen KH
Arch Dis Child; 1992 Sep; 67(9):1077-9. PubMed ID: 1417048
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid.
Szefler SJ
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):175-83. PubMed ID: 10518844
[TBL] [Abstract][Full Text] [Related]
6. Lung deposition of inhaled drugs increases with age.
Onhøj J; Thorsson L; Bisgaard H
Am J Respir Crit Care Med; 2000 Nov; 162(5):1819-22. PubMed ID: 11069819
[TBL] [Abstract][Full Text] [Related]
7. Aerosol delivery of nebulised budesonide in young children with asthma.
Schueepp KG; Devadason SG; Roller C; Minocchieri S; Moeller A; Hamacher J; Wildhaber JH
Respir Med; 2009 Nov; 103(11):1738-45. PubMed ID: 19540100
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of budesonide in children with asthma.
Pedersen S; Steffensen G; Ekman I; Tönnesson M; Borgå O
Eur J Clin Pharmacol; 1987; 31(5):579-82. PubMed ID: 3549321
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
Agertoft L; Pedersen S; Nikander K
J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
[TBL] [Abstract][Full Text] [Related]
10. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide.
Nikander K; Agertoft L; Pedersen S
J Asthma; 2000 Aug; 37(5):451-9. PubMed ID: 10983623
[TBL] [Abstract][Full Text] [Related]
11. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
Adams N; Bestall JM; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2005 Apr; (2):CD002310. PubMed ID: 15846637
[TBL] [Abstract][Full Text] [Related]
12. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
Agertoft L; Pedersen S
Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
[TBL] [Abstract][Full Text] [Related]
13. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma.
Vogelmeier C; Kardos P; Hofmann T; Canisius S; Scheuch G; Muellinger B; Nocker K; Menz G; Rabe KF
Eur Respir J; 2015 May; 45(5):1273-82. PubMed ID: 25504995
[TBL] [Abstract][Full Text] [Related]
14. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
Berg EB; Picard RJ
Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
[TBL] [Abstract][Full Text] [Related]
15. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
[TBL] [Abstract][Full Text] [Related]
16. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
17. Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infant?
Turpeinen M; Nikander K; Malmberg LP; Pelkonen A
J Aerosol Med; 1999; 12(3):171-6. PubMed ID: 10623333
[TBL] [Abstract][Full Text] [Related]
18. A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children.
Schüepp KG; Devadson S; Roller C; Wildhaber JH
Swiss Med Wkly; 2004 Apr; 134(13-14):198-200. PubMed ID: 15106033
[TBL] [Abstract][Full Text] [Related]
19. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
20. [Nebulisation in childhood asthma].
Siret D; Luc C; Dubus JC
Arch Pediatr; 2005 Aug; 12 Suppl 2():S139-41. PubMed ID: 16129327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
